CalciMedica, Inc.
CALC
$2.06
$0.063.00%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 2.21% | -2.62% | -3.85% | 19.26% | 62.86% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 10.65% | 8.18% | 12.20% | 33.37% | 54.13% |
| Operating Income | -10.65% | -8.18% | -12.20% | -33.37% | -54.13% |
| Income Before Tax | 60.12% | 52.81% | 52.95% | 36.38% | -339.12% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 60.12% | 52.81% | 52.95% | 36.38% | -339.12% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 60.12% | 52.81% | 52.95% | 36.38% | -339.12% |
| EBIT | -10.65% | -8.18% | -12.20% | -33.37% | -54.13% |
| EBITDA | -10.68% | -8.15% | -12.20% | -33.43% | -54.28% |
| EPS Basic | 95.50% | 93.51% | 96.55% | 97.06% | 76.82% |
| Normalized Basic EPS | 81.65% | 92.69% | 96.36% | 96.97% | 95.06% |
| EPS Diluted | 95.48% | 93.50% | 96.54% | 97.06% | 76.82% |
| Normalized Diluted EPS | 81.64% | 92.69% | 96.36% | 96.97% | 95.06% |
| Average Basic Shares Outstanding | 151.39% | 208.57% | 385.39% | 2,398.90% | 5,338.24% |
| Average Diluted Shares Outstanding | 153.03% | 210.96% | 389.80% | 2,426.19% | 5,338.24% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |